Live
- Awareness Program in agricultural College on the Dangers of Drug Abuse for Youth
- 3500-Year-Old Menhir in Kamsanpally Village: A Call for Preservation
- The Role of Artificial Intelligence in Radiology: Transforming Diagnosis and Patient Care
- Hindustan Zinc Ltd. Signs MoU with Rajasthan Government to Invest Rs 36 Crores in Education Development
- Sales and Marketing: Synchronising Steps for Success
- MATTER begins deliveries of AERA from Ahmedabad, inaugurates first of its kind Experience Hub
- Transforming Education Infrastructure is the key to National Development: Neeraj Sharma, Auxilo Finserve
- Crimson Becomes the First Indian School to Receive WELL Health-Safety Certification for Measures to Boost Physical and Mental Wellbeing
- Trackon Celebrates 20 Years of Innovation and Growth in Logistics
- Hero Motocorp showcases its future mobility vision at Eicma 2024
Antibodies in mild Coronavirus patients decline rapidly
In people with mild cases of COVID-19, antibodies against the novel coronavirus may drop sharply over the first three months after infection, according to a research which says the levels may decrease by roughly half every 73 days
California: In people with mild cases of COVID-19, antibodies against the novel coronavirus may drop sharply over the first three months after infection, according to a research which says the levels may decrease by roughly half every 73 days.
Scientists, including Javier Ibarrondo from the University of California Los Angeles (UCLA), noted that if the declining antibody levels sustained at that rate, they might disappear within about a year. Previous studies had suggested that antibodies which block the novel coronavirus are short-lived, but the rate at which they decrease has not been carefully defined.
According to the scientists, the current research, published in the New England Journal of Medicine, is the first to carefully estimate the disappearance rate of antibody proteins which are part of the body's humoral immunity.
"Our findings raise concern that humoral immunity against SARS-CoV-2 may not be long lasting in persons with mild illness, who compose the majority of persons with Covid-19," the scientists wrote in the research.
In the study, the researchers assessed 20 women and 14 men who recovered from mild cases of COVID-19.
They conducted antibody tests of the patients' blood samples drawn at an average of 36 days and 82 days after the initial symptoms of infection. The scientists said the findings raise concerns about the validity of antibody-based "immunity passports," which are documents that certify a person is immune to COVID-19.
